Conference Support for 16th International Workshop on KSHV and Related Agents, Pu

第 16 届 KSHV 及相关药物国际研讨会会议支持，浦

• 批准号: 8541332
• 负责人: Bala Chandran
• 金额: $ 0.7万
• 依托单位: ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-05-01 至 2014-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8541332
• 关键词: AIDS/HIV problem; Advisory Committees; African; Animal Model; Animals; Antiviral Agents; Applications Grants; Area; Attention; Biology; Biotechnology; Canada; Chicago; China; Chronic; Clinical; Commit; Communities; Country; Data; Development; Diagnostic; Disease; Educational workshop; Elderly; Epidemiology; Europe; Fees; Fibromatoses; Finland; Fostering; Foundations; France; Funding; Gene Expression; Geographic Locations; Germany; Goals; Group Meetings; HIV; Herpesviridae; Herpesviridae Infections; Human; Human Herpesvirus 4; Human Herpesvirus 8; Immune; Immune response; Immunocompromised Host; Immunosuppression; Individual; Infection; International; Intervention; Israel; Italy; Kaposi Sarcoma; Knowledge; Location; Lymphomagenesis; Macaca mulatta; Malignant Neoplasms; Medicine; Methods; Mexico; Mission; Molecular; Molecular Biology; Multicentric Angiofollicular Lymphoid Hyperplasia; Murine herpesvirus 68; National Institute of Allergy and Infectious Disease; National Institute of Dental and Craniofacial Research; Oral; Participant; Pathogenesis; Pathology; Pharmacologic Substance; Population; Postdoctoral Fellow; Prevention; Rare Diseases; Reagent; Request for Applications; Research; Research Personnel; Retroperitoneal Space; Rhadinovirus; Risk; Role; Running; Safety; Saimiriine Herpesvirus 2; Scandinavia; Science; Scientist; Site; South America; Therapeutic; Travel; United Kingdom; United States National Institutes of Health; Universities; Vaccines; Validation; Viral; Viral Genes; Viral Pathogenesis; Virus; Woman; abstracting; blood bank contamination; cancer therapy; cost; data exchange; gammaherpesvirus; man; medical schools; meetings; member; men; neoplastic; nonhuman primate; novel; oncology; posters; pre-doctoral; primary effusion lymphoma; programs; public health relevance; reactivation from latency; research and development; symposium; tumor; tumorigenesis; tumorigenic; viral detection; volunteer; working group

DESCRIPTION (provided by applicant): Kaposi's sarcoma herpesvirus (KSHV) is the most recently identified tumorigenic herpesvirus infecting man. KSHV is the etiologic agent of Kaposi's sarcoma (KS), primary effusion lymphoma and multicentric Castleman's disease. KS is a multifocal tumor observed in elderly Mediterranean men, the immunocompromised and untreated HIV-infected individuals. It is the most frequent tumor of HIV-infected individuals and is the leading human cancer in sub- Saharan African countries. This "16th International Workshop on KSHV and Related Agents" is an annual meeting for research scientists from around the world studying all aspects of the biology of KSHV and related agents. The objective of this meeting is that scientists will share their recent findings, network and collaborate. Contributions to the meeting from groups working on related gammaherpesviruses are also expected. These viruses include others infecting humans (Epstein Barr virus) and those infecting animals, such as murine herpesvirus- 68, rhesus rhadinovirus and herpesvirus saimiri. The meeting will run for four days and will cover aspects such as clinical settings, epidemiology, pathology, treatment/Intervention, molecular biology, molecular mechanisms of tumorigenesis, and immune evasion. This conference grant application requests funds to reduce the travel and registration costs to US pre-and post- doctoral trainees in viral oncology. Delegates: The scientific program advisory committee consists of three members of local organizing committee and 19 other members. Five of the members are from abroad (Europe/China), and six of them are women. The entire committee represents diverse scientific expertise, geographic location and institutional affiliations. It is also predicted that there will be a diverse group of participants/delegates in attendance, as determined by attendance at the previous meeting in from 1999-2012. In addition to USA delegates, participants are anticipated from the United Kingdom, Canada, China, Finland, France, Germany, Italy, Israel, Mexico, Scandinavia and South America. Meeting location and dates: The meeting will be held on June 30-July 3, 2013 at the Fiesta Americana Hotel, Puerto Vallarta, Mexico.

描述(申请人提供)：卡波西肉瘤疱疹病毒(KSHV)是最近发现的感染人类的致瘤性疱疹病毒。KSHV是Kaposi肉瘤(KS)、原发性渗出性淋巴瘤和多中心Castleman病的病原体。KS是一种多灶性肿瘤，见于地中海老年男子，即免疫功能低下和未经治疗的艾滋病毒感染者。它是艾滋病毒感染者中最常见的肿瘤，也是撒哈拉以南非洲国家的主要人类癌症。这次“第16届KSHV及相关病原体国际研讨会”是世界各地研究KSHV及相关病原体生物学各方面的研究科学家的年度会议。这次会议的目的是让科学家们分享他们的最新发现，建立网络并进行合作。预计研究相关伽马疱疹病毒的小组也将向会议发表意见。这些病毒包括其他感染人类的病毒(爱泼斯坦-巴尔病毒)和那些感染动物的病毒，如小鼠疱疹病毒-68、恒河猴轮状病毒和萨伊里疱疹病毒。会议为期四天，将涵盖临床环境、流行病学、病理学、治疗/干预、分子生物学、肿瘤发生的分子机制和免疫逃避等方面。这项会议拨款申请要求提供资金，以减少美国病毒肿瘤学博士后和博士后学员的旅费和注册费用。代表们：科学计划咨询委员会由3名当地组委会成员和19名其他成员组成。其中5名成员来自国外(欧洲/中国)，其中6名为女性。整个委员会代表了不同的科学专长、地理位置和机构背景。还预计将有不同的与会者/代表出席，这将取决于1999-2012年举行的上一次会议的出席情况。除美国代表外，预计还将有来自英国、加拿大、中国、芬兰、法国、德国、意大利、以色列、墨西哥、斯堪的纳维亚和南美洲的代表参加。会议地点和日期：会议将于2013年6月30日至7月3日在墨西哥巴亚尔塔港的嘉年华美国酒店举行。